The MTAcooperative PRMT5 inhibitor AM9747 exhibits robust antitumor activity in combination with clinically relevant chemotherapies and targeted agents in MTAP null tumor models Katherine Slemmons,Brian Belmontes,Siyuan Liu,Jodi Moriguchi, Antonia Policheni,Paul E. HughesCANCER RESEARCH（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
